Date | Price Target | Rating | Analyst |
---|---|---|---|
4/10/2024 | Overweight → Sector Weight | KeyBanc Capital Markets | |
3/20/2024 | $16.00 | Neutral → Buy | Citigroup |
2/26/2024 | $14.00 | Outperform | Leerink Partners |
1/3/2024 | $14.00 | Overweight | Barclays |
12/15/2023 | $17.50 → $17.00 | Equal-Weight → Overweight | Morgan Stanley |
12/13/2023 | $20.00 → $11.00 | Overweight → Neutral | JP Morgan |
10/19/2023 | $18.00 | Hold → Buy | Truist |
9/22/2023 | $20.00 | Buy | Citigroup |
MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended June 30, 2024, before market open on Wednesday, August 7, 2024 and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 888-596-4144 (646-968-2525 outside the U.S. and Canada) using conference code number 9123341. A live webcast and replay of the call will be available at the Investor Relations s
MURRAY, Utah, May 08, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months ended March 31, 2024 and updated full year 2024 outlook. First Quarter 2024 Results: Revenue of $603.9 million, up $58.3 million or 10.7% compared to the same period last year.GAAP net loss of $35.1 million, compared to net income of $1.6 million in the same period last year.Adjusted EBITDA of $152.2 million, compared to adjusted EBI
MURRAY, Utah, April 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended March 31, 2024, before market open on Wednesday, May 8, 2024 and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 888-596-4144 (646-968-2525 outside the U.S. and Canada) using conference code number 9123341. A live webcast and replay of the call will be available at the Investor Relations
MURRAY, Utah, Feb. 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months and year ended December 31, 2023. Fourth Quarter 2023 Results: Revenue of $575.1 million, up $41.8 million or 7.8% compared to the same period last yearGAAP net income of $1.4 million, compared to a net loss of $36.6 million in the same period last yearAdjusted EBITDA of $167.7 million, up $42.1 million or 33.5% compared to the same period last year Full Year 2023 Results: Revenue
4 - R1 RCM Inc. /DE (0001910851) (Issuer)
4 - R1 RCM Inc. /DE (0001910851) (Issuer)
4 - R1 RCM Inc. /DE (0001910851) (Issuer)
4 - R1 RCM Inc. /DE (0001910851) (Issuer)
SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)
SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)
SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)
SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)
MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended June 30, 2024, before market open on Wednesday, August 7, 2024 and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 888-596-4144 (646-968-2525 outside the U.S. and Canada) using conference code number 9123341. A live webcast and replay of the call will be available at the Investor Relations s
MURRAY, Utah, June 17, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it will host a virtual event on Thursday, June 27, 2024 at 11:00 AM ET. To register, click here. The event will feature Steve Albert, Executive Vice President and Chief Product Officer, and Brian Gambs, Executive Vice President and Chief Technology Officer. Steve and Brian will provide an overview of the R1 Platform and key areas of innovation as well as value creation for R1 and its customers. They will also highlight key advantages of the
MURRAY, Utah, May 24, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the 2024 Jefferies Global Healthcare Conference on Wednesday, June 5, 2024, at 10:30am ET. A live audio webcast of this presentation will be available on the Investor Relations section of R1's website at r1rcm.com. A replay of the webcast will be available for 90 days following the live webcast. About R1 RCM R1 is a leading provider of technology-driven solutions that transform the patient experience and financial performance of
MURRAY, Utah, May 08, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months ended March 31, 2024 and updated full year 2024 outlook. First Quarter 2024 Results: Revenue of $603.9 million, up $58.3 million or 10.7% compared to the same period last year.GAAP net loss of $35.1 million, compared to net income of $1.6 million in the same period last year.Adjusted EBITDA of $152.2 million, compared to adjusted EBI
S-8 - R1 RCM Inc. /DE (0001910851) (Filer)
8-K - R1 RCM Inc. /DE (0001910851) (Filer)
10-Q - R1 RCM Inc. /DE (0001910851) (Filer)
8-K - R1 RCM Inc. /DE (0001910851) (Filer)
KeyBanc Capital Markets downgraded R1 RCM from Overweight to Sector Weight
Citigroup upgraded R1 RCM from Neutral to Buy and set a new price target of $16.00
Leerink Partners initiated coverage of R1 RCM with a rating of Outperform and set a new price target of $14.00
Barclays initiated coverage of R1 RCM with a rating of Overweight and set a new price target of $14.00
Deutsche Bank analyst George Hill maintains R1 RCM (NASDAQ:RCM) with a Hold and raises the price target from $14 to $16.
U.S. stocks started the week on a neutral note, with the S&P 500 and Nasdaq 100 indices hovering around the flatline by midday trading in New York. This comes after both indices reached fresh record highs last Friday. Small-cap stocks outperformed their larger counterparts, with the iShares Russell 2000 ETF (NYSE:IWM) gaining 0.8%. Meanwhile, blue-chip stocks of the Dow Jones index dipped slightly by 0.1%. Across the Atlantic, French legislative elections concluded with a surprising victory for a left-wing bloc, though they failed to secure an absolute majority. This news led to a downturn in French stocks on the first trading day post-election, as investors worried about potential tax
Shares of Arhaus, Inc. (NASDAQ:ARHS) fell sharply during Monday's session. Jefferies analyst Jonathan Matuszewski downgraded Arhaus from Buy to Hold and lowered the price target from $22 to $16. Arhaus shares dipped 7.9% to $14.55 on Monday. Here are some other stocks moving in today’s mid-day session. Gainers Morphic Holding, Inc. (NASDAQ:MORF) shares jumped 75% to $55.72 after Eli Lilly agreed to buy the company for $57 per share in cash. Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) climbed 71% to $6.97 after jumping around 50% on Friday. SRIVARU Holding Limited (NASDAQ:SVMH) shares climbed 61.3% to $0.2549 after the company announced the deployment of advanced
Rachel Wilson appointed as Chief Financial Officer (CFO) James Hardie Industries plc ((ASX: JHX, NYSE:JHX), the world's #1 producer and marketer of high-performance fiber cement and fiber gypsum building solutions, today announced the appointment of Ms. Rachel Wilson as Chief Financial Officer, effective immediately. As a member of the global executive team, Ms. Wilson will report directly to Chief Executive Officer Aaron Erter. Ms. Wilson was appointed after Jason Miele stepped down as Chief Financial Officer. Mr. Miele will remain with the Company for three months as an advisor to the Chief Executive Officer for special projects and will thereafter depart the organization. "I would li
MURRAY, Utah, Aug. 12, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the appointment of Agnes Bundy Scanlan, president of The Cambridge Group LLC, to the company's board of directors, effective August 11, 2021. Ms. Bundy Scanlan has more than 30 years of experience across regulatory risk management, compliance, and consumer financial protection. She has served as president of The Cambridge Group LLC, a regulatory risk management advisory firm, since May 2020. Prior to this role, Ms. Bundy Scanlan served as senior advisor at Trelian
MURRAY, Utah, Aug. 02, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that Jay Sreedharan will join the executive team as its first chief technology and digital officer. Sreedharan will lead R1's efforts in creating digital solutions that drive higher-value experiences for patients and providers. In this role, Sreedharan will be responsible for delivering on R1's promise of digital transformation and growth, including strategy, engineering, product development, architecture and implementation, as well as future digital M&A and partn
Conversion of Preferred Stock to Shares of Common Stock to Enhance Alignment with Common Shareholders Ascension and TowerBrook Committed to Supporting Sustainable Long-Term Growth CHICAGO, Jan. 06, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, announced that it has entered into an agreement with TCP-ASC ACHI Series LLLP, an investment vehicle jointly owned by Ascension Health Alliance (“Ascension”) and investment funds affiliated with TowerBrook Capital Partners L.P. (“TowerBrook”), for the conversion of all of the 8.00% Series A Convertible Preferred Stock (the “Preferre